BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18456377)

  • 1. Immunodeficiency-associated lymphomas.
    Tran H; Nourse J; Hall S; Green M; Griffiths L; Gandhi MK
    Blood Rev; 2008 Sep; 22(5):261-81. PubMed ID: 18456377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphomas in immunocompromised hosts].
    Berger F; Delecluse HJ
    Rev Prat; 1993 Sep; 43(13):1661-4. PubMed ID: 8303184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
    Filipovich AH; Mathur A; Kamat D; Kersey JH; Shapiro RS
    Immunodeficiency; 1994; 5(2):91-112. PubMed ID: 8032367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficiency-related Hodgkin lymphoma and its mimics.
    Said JW
    Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.
    Okano M; Gross TG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):403-13. PubMed ID: 17547505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of immunodeficiency to lymphoid malignancy.
    Kersey JH; Shapiro RS; Filipovich AH
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorders associated with congenital immunodeficiencies.
    Elenitoba-Johnson KS; Jaffe ES
    Semin Diagn Pathol; 1997 Feb; 14(1):35-47. PubMed ID: 9044508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiencies: genetic risk factors for lymphoma.
    Filipovich AH; Mathur A; Kamat D; Shapiro RS
    Cancer Res; 1992 Oct; 52(19 Suppl):5465s-5467s. PubMed ID: 1327508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanisms.
    Brusamolino E; Pagnucco G; Bernasconi C
    Haematologica; 1989; 74(6):605-22. PubMed ID: 2560763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-associated lymphoproliferative disorders: classification and treatment.
    Carbone A; Gloghini A; Dotti G
    Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
    Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
    J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.
    Linke-Serinsöz E; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2017 Jul; 34(4):352-363. PubMed ID: 28506687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma in the immunocompromised.
    Sita-Lumsden A; Harris P; Bower M
    Br J Hosp Med (Lond); 2010 May; 71(5):264-8. PubMed ID: 20448494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders.
    Okano M; Gross TG
    Am J Med Sci; 2000 Jun; 319(6):392-6. PubMed ID: 10875296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.
    Gratzinger D; de Jong D; Jaffe ES; Chadburn A; Chan JK; Goodlad JR; Said J; Natkunam Y
    Am J Clin Pathol; 2017 Feb; 147(2):188-203. PubMed ID: 28395105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
    Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
    Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.